Angiotensin II induces membrane trafficking of natively expressed transient receptor potential vanilloid type 4 channels in hypothalamic 4B cells

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 8, 2014, Pages R945-R955

  Saxena, Ashwini ^a   Bachelor, Martha ^a   Park, Yong H ^a   Carreno, Flavia R ^b   Nedungadi, T Prashant ^a   Cunningham, J Thomas ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

4B; Angiotensin; Hypothalamus; SRC kinase; SRY; TRPV4

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN II; ARGIPRESSIN; CALCIUM; CORTICOTROPIN RELEASING FACTOR; CYTOSKELETON PROTEIN; GSK 1016790A; LOSARTAN; MICROTUBULE ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR SOX; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR ANTAGONIST; ANGIOTENSIN 1 RECEPTOR; HC-067047; LEUCINE; MORPHOLINE DERIVATIVE; N-(1-((4-(2-(((2,4-DICHLOROPHENYL)SULFONYL)AMINO)-3-HYDROXYPROPANOYL)-1-PIPERAZINYL)CARBONYL)-3-METHYLBUTYL)-1-BENZOTHIOPHENE-2-CARBOXAMIDE; PROTEIN TYROSINE KINASE; PYRROLE DERIVATIVE; SULFONAMIDE; TRPV4 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CELL MIGRATION; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; MOLECULAR IMAGING; NEUROSECRETORY CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL LINE; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CALCIUM; CELL LINE; CELLS, CULTURED; HYPOTHALAMUS; LEUCINE; MEMBRANE MICRODOMAINS; MORPHOLINES; PROTEIN TRANSPORT; PYRROLES; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SULFONAMIDES; TRPV CATION CHANNELS;

EID: 84908076565     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00224.2014     Document Type: Article

References (77)

1. Babatin DM, Lee SS. Vasopressin antagonists and dilutional hyponatremia. Can J Gastroenterol 18: 117-118, 2004.
2. Bagher P, Beleznai T, Kansui Y, Mitchell R, Garland CJ, Dora KA. Low intravascular pressure activates endothelial cell TRPV4 channels, local Ca2 events, and IKCa channels, reducing arteriolar tone. Proc Natl Acad Sci USA 109: 18174-18179, 2012.
3. Benfenati V, Amiry-Moghaddam M, Caprini M, Mylonakou MN, Rapisarda C, Ottersen OP, Ferroni S. Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes. Neuroscience 148: 876-892, 2007.
4. Bernicker E. Cecil Textbook of Medicine (20th Ed.), edited by Cecil RL. Philadelphia, PA: Saunders, 1998.
5. Bernstein KE, Marrero MB. The Importance of tyrosine phosphorylation in angiotensin II signaling. Trends Cardiovasc Med 6: 179-187, 1996.
6. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 290: 1972-1974, 2000.
7. Boychuk CR, Zsombok A, Tasker JG, Smith BN. Rapid glucocorticoi d-induced activation of TRP and CB1 receptors causes biphasic modulation of glutamate release in gastric-related hypothalamic preautonomic neurons. Frontiers Neurosci 7: 3, 2013.
8. Carreno FR, Goni CN, Castro LM, Ferro ES. 14-3-3 epsilon modulates the stimulated secretion of endopeptidase 24.15. J Neurochem 93: 10-25, 2005.
9. Carreno FR, Ji LL, Cunningham JT. Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats. Am J Physiol Regul Integr Comp Physiol 296: R454-R466, 2009.
10. Cunningham JT, Nissen R, Renaud LP. Perinuclear zone and diagonal band lesions enhance angiotensin responses of rat supraoptic neurons. Am J Physiol Regul Integr Comp Physiol 267: R916-R922, 1994.
11. Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
12. Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23: 4850-4857, 2003.
13. Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 146: 4292-4301, 2005.
14. Di S, Maxson MM, Franco A, Tasker JG. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J Neurosci 29: 393-401, 2009.
15. Dibas A, Mia AJ, Yorio T. Is protein kinase C alpha (PKC alpha) involved in vasopressin-induced effects on LLC-PK1 pig kidney cells? Biochem Molec Biol Internatl 39: 581-588, 1996.
16. Douglas WW, Poisner AM. Calcium movement in the neurohypophysis of the rat and its relation to the release of vasopressin. J Physiol 172: 19-30, 1964.
17. Douglas WW, Poisner AM. Stimulus-secretion coupling in a neurosecretory organ: the role of calcium in the release of vasopressin from the neurohypophysis. J Physiol 172: 1-18, 1964.
18. Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease. Progr Biophysics Molec Biol 103: 2-17, 2010.
19. Ferrario CM. Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview. Drugs 39, Suppl 2: 1-8, 1990.
20. Ferrario CM. The renin-angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol 15, Suppl 3: S1-S5, 1990.
21. Filosa JA, Yao X, Rath G. TRPV4 and the regulation of vascular tone. J Cardiovasc Pharmacol 61: 113-119. doi:10.1097/FJC.0b013e318279ba42.
22. Gianotti RJ, Cardenas A. Hyponatraemia and cirrhosis. Gastroenterology Rep 2: 21-26, 2014.
23. Gitelman SE, Feldman BJ, Rosenthal SM. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients. Am J Med 119: S54-S58, 2006.
24. Goldsmith SR. Hyponatremia in heart failure: time for a trial. J Card Fail 19: 398-400, 2013.
25. Grobe JL, Xu D, Sigmund CD. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology 23: 187-193, 2008.
26. Gupta S, Cheetham TD, Lambert HJ, Roberts C, Bourn D, Coulthard MG, Ball SG. Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: the pathophysiology of nephrogenic syndrome of inappropriate antidiuresis. Eur J Endocrinol 161: 503-508, 2009.
27. Hisatsune C, Kuroda Y, Nakamura K, Inoue T, Nakamura T, Michikawa T, Mizutani A, Mikoshiba K. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J Biol Chem 279: 18887-18894, 2004.
28. Jiang X, Newell EW, Schlichter LC. Regulation of a TRPM7-like current in rat brain microglia. J Biol Chem 278: 42867-42876, 2003.
29. Jin M, Wu Z, Chen L, Jaimes J, Collins D, Walters ET, O’Neil RG. Determinants of TRPV4 activity following selective activation by small molecule agonist GSK1016790A. PLos One 6: e16713, 2011.
30. Jin X, Morsy N, Winston J, Pasricha PJ, Garrett K, Akbarali HI. Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 287: C558-C563, 2004.
31. Johnson AK, Cunningham JT, Thunhorst RL. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin Exper Pharmacol Physiol 23: 183-191, 1996.
32. Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J Endocrinol 195: 199-211, 2007.
33. Kageyama K, Itoi K, Iwasaki Y, Niioka K, Watanuki Y, Yamagata S, Nakada Y, Das G, Suda T, Daimon M. Stimulation of corticotropinreleasing factor gene expression by FosB in rat hypothalamic 4B cells. Peptides 51: 59-64, 2014.
34. Kasckow J, Mulchahey JJ, Aguilera G, Pisarska M, Nikodemova M, Chen HC, Herman JP, Murphy EK, Liu Y, Rizvi TA, Dautzenberg FM, Sheriff S. Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line. J Neuroendocrinol 15: 521-529, 2003.
35. Kashani A, Landaverde C, Medici V, Rossaro L. Fluid retention in cirrhosis: pathophysiology and management. QJM 101: 71-85, 2008.
36. Kleiber AC, Zheng H, Sharma NM, Patel KP. Chronic AT1 receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure. Am J Physiol Heart Circ Physiol 298: H1546-H1555, 2010.
37. Kumar S, Rubin S, Mather PJ, Whellan DJ. Hyponatremia and vasopressin antagonism in congestive heart failure. Clin Cardiol 30: 546-551, 2007.
38. LeJemtel TH, Serrano C. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure. Int J Cardiol 120: 1-9, 2007.
39. Leng G, Ludwig M. Neurotransmitters and peptides: whispered secrets and public announcements. J Physiol 586: 5625-5632, 2008.
40. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand 177: 17-26, 2003.
41. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103: 525-535, 2000.
42. Liu Y, Kalintchenko N, Sassone-Corsi P, Aguilera G. Inhibition of corticotrophin-releasing hormone transcription by inducible cAMP-early repressor in the hypothalamic cell line, 4B. J Neuroendocrinol 18: 42-49, 2006.
43. McKinley MJ, Allen AM, May CN, McAllen RM, Oldfield BJ, Sly D, Mendelsohn FAO. Neural pathways from the lamina terminalis influencing cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol 28: 990-992, 2001.
44. Mercado J, Baylie R, Navedo MF, Yuan C, Scott JD, Nelson MT, Brayden JE, Santana LF. Local control of TRPV4 channels by AKAP150-targeted PKC in arterial smooth muscle. J Gen Physiol 143: 559-575, 2014.
45. Midde K, Rich R, Saxena A, Gryczynski I, Borejdo J, Das HK. Membrane topology of human presenilin-1 in SK-N-SH cells determined by fluorescence correlation spectroscopy and fluorescent energy transfer. Cell Biochem Biophysics. In press.
46. Mizuno A, Matsumoto N, Imai M, Suzuki M. Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol 285: C96-C101, 2003.
47. Montell C. The TRP superfamily of cation channels. Sci STKE 2005: re3, 2005.
48. Morin D, Tenenbaum J, Ranchin B, Durroux T. Nephrogenic syndrome of inappropriate antidiuresis. Int J Pediatr 2012: 937175, 2012.
49. Nedungadi TP, Cunningham JT. Differential regulation of TRPC4 in the vasopressin magnocellular system by water deprivation and hepatic cirrhosis in the rat. Am J Physiol Regul Integr Comp Physiol 306: R304-R314, 2014.
50. Nilius B, Owsianik G. Channelopathies converge on TRPV4. Nature Genetics 42: 98-100, 2010.
51. Nilius B, Voets T. The puzzle of TRPV4 channelopathies. EMBO Reports 14: 152-163, 2013.
52. Nishino K, Hattori N, Tanaka S, Shiota K. DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J Biol Chem 279: 22306-22313, 2004.
53. Okuya S, Inenaga K, Kaneko T, Yamashita H. Angiotensin II sensitive neurons in the supraoptic nucleus, subfornical organ and anteroventral third ventricle of rats in vitro. Brain Res 402: 58-67, 1987.
54. Pan Z, Yang H, Reinach PS. Transient receptor potential (TRP) gene super-family encoding cation channels. Human Genomics 5: 108-116, 2011.
55. Plant TD, Strotmann R. TRPV4: A Multifunctional Nonselective Cation Channel With Complex Regulation, edited by Liedtke WB, HEller S. Boca Raton, FL: CRC, 2007, chapt. 9.
56. Pochynyuk O, Zaika O, O’Neil RG, Mamenko M. Novel insights into TRPV4 function in the kidney. Pflügers Arch 465: 177-186, 2013.
57. Saito Y, Berk BC. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33: 3-7, 2001.
58. Sharma NM, Llewellyn TL, Zheng H, Patel KP. Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: role for PIN. Am J Physiol Heart Circ Physiol 305: H843-H855, 2013.
59. Shukla AK, Kim J, Ahn S, Xiao K, Shenoy SK, Liedtke W, Lefkowitz RJ. Arresting a transient receptor potential (TRP) channel: beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4. J Biol Chem 285: 30115-30125. doi:10.1074/jbc.M110.141549.
60. Sonkusare SK, Bonev AD, Ledoux J, Liedtke W, Kotlikoff MI, Heppner TJ, Hill-Eubanks DC, Nelson MT. Elementary Ca2 signals through endothelial TRPV4 channels regulate vascular function. Science 336: 597-601, 2012.
61. Sonnino S, Prinetti A. Membrane domains and the “lipid raft” concept. Curr Med Chem 20: 4-21, 2013.
62. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, McIntyre P, Jegla T, Bevan S, Patapoutian A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829, 2003.
63. Sudbury JR, Bourque CW. Dynamic and permissive roles of TRPV1 and TRPV4 channels for thermosensation in mouse supraoptic magnocellular neurosecretory neurons. J Neurosci 33: 17160-17165, 2013.
64. Sullivan MN, Earley S. TRP channel Ca2 sparklets: fundamental signals underlying endothelium-dependent hyperpolarization. Am J Physiol Cell Physiol 305: C999-C1008, 2013.
65. Thomas WG, Qian H, Smith NJ. When 6 is 9: “uncoupled” AT1 receptors turn signalling on its head. Cell Molec Life Sci 61: 2687-2694, 2004.
66. Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, Chendrimada TP, Lashinger ES, Gordon E, Evans L, Misajet BA, Demarini DJ, Nation JH, Casillas LN, Marquis RW, Votta BJ, Sheardown SA, Xu X, Brooks DP, Laping NJ, Westfall TD. N-((1S)-1-{[4((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino-}-3-hydroxypropanoyl)-1piperazinyl]carbonyl-}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity. Part I. J Pharmacol Exper Therap 326: 432-442, 2008.
67. Vazquez G, Wedel BJ, Kawasaki BT, Bird GS, Putney JW, Jr. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J Biol Chem 279: 40521-40528, 2004.
68. Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Eur Heart J 30: 679-688, 2009.
69. Verma P, Kumar A, Goswami C. TRPV4-mediated channelopathies. Channels 4: 319-328, 2010.
70. Violin JD, Lefkowitz RJ. Arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28: 416-422, 2007.
71. Walch JD, Carreno FR, Cunningham JT. Intracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats. Exp Physiol 98: 922-933, 2013.
72. Xu H, Fu Y, Tian W, Cohen DM. Glycosylation of the osmoresponsive transient receptor potential channel TRPV4 on Asn-651 influences membrane trafficking. Am J Physiol Renal Physiol 290: F1103-F1109, 2006.
73. Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, Cohen DM. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem 278: 11520-11527, 2003.
74. Yang CR, Phillips MI, Renaud LP. Angiotensin II receptor activation depolarizes rat supraoptic neurons in vitro. Am J Physiol Regul Integr Comp Physiol 263: R1333-R1338, 1992.
75. Yin G, Yan C, Berk BC. Angiotensin II signaling pathways mediated by tyrosine kinases. Intl J Biochem Cell Biol 35: 780-783, 2003.
76. Zhang K, Li YF, Patel KP. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 282: R1006-R1015, 2002.
77. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 45: 717-723, 2005.